HUS1400060I1 - Antimikrobiális hatású pleuromutilin-származékok - Google Patents
Antimikrobiális hatású pleuromutilin-származékokInfo
- Publication number
- HUS1400060I1 HUS1400060I1 HUS1400060C HUS1400060C HUS1400060I1 HU S1400060 I1 HUS1400060 I1 HU S1400060I1 HU S1400060 C HUS1400060 C HU S1400060C HU S1400060 C HUS1400060 C HU S1400060C HU S1400060 I1 HUS1400060 I1 HU S1400060I1
- Authority
- HU
- Hungary
- Prior art keywords
- antimicrobials
- pleuromutilin derivatives
- pleuromutilin
- derivatives
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title 1
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical class C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/36—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9722817.5A GB9722817D0 (en) | 1997-10-29 | 1997-10-29 | Novel compounds |
GBGB9813689.8A GB9813689D0 (en) | 1998-06-25 | 1998-06-25 | Novel compounds |
PCT/GB1998/003211 WO1999021855A1 (en) | 1997-10-29 | 1998-10-27 | Pleuromutilin derivatives as antimicrobials |
HU0004040A HU229792B1 (en) | 1997-10-29 | 1998-10-27 | Pleuromutilin derivatives as antimicrobials |
Publications (1)
Publication Number | Publication Date |
---|---|
HUS1400060I1 true HUS1400060I1 (hu) | 2016-09-28 |
Family
ID=26312507
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004040A HU229792B1 (en) | 1997-10-29 | 1998-10-27 | Pleuromutilin derivatives as antimicrobials |
HUS1400060C HUS1400060I1 (hu) | 1997-10-29 | 2014-12-18 | Antimikrobiális hatású pleuromutilin-származékok |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004040A HU229792B1 (en) | 1997-10-29 | 1998-10-27 | Pleuromutilin derivatives as antimicrobials |
Country Status (36)
Country | Link |
---|---|
US (3) | US6281226B1 (hu) |
EP (3) | EP1452534A1 (hu) |
JP (2) | JP4227729B2 (hu) |
KR (1) | KR100538721B1 (hu) |
CN (1) | CN1205211C (hu) |
AR (1) | AR015987A1 (hu) |
AT (2) | ATE277925T1 (hu) |
AU (1) | AU742167C (hu) |
BR (1) | BR9814747B1 (hu) |
CA (1) | CA2307551C (hu) |
CO (1) | CO5021129A1 (hu) |
CY (2) | CY2007028I1 (hu) |
CZ (1) | CZ298543B6 (hu) |
DE (2) | DE69826704T3 (hu) |
DK (2) | DK1930330T3 (hu) |
DZ (1) | DZ2634A1 (hu) |
EG (1) | EG24177A (hu) |
ES (2) | ES2371205T3 (hu) |
FR (1) | FR07C0057I2 (hu) |
HK (1) | HK1031376A1 (hu) |
HU (2) | HU229792B1 (hu) |
IL (2) | IL135811A0 (hu) |
LU (1) | LU91372I2 (hu) |
MY (1) | MY130665A (hu) |
NL (1) | NL300304I2 (hu) |
NO (3) | NO327392B1 (hu) |
NZ (1) | NZ504203A (hu) |
PE (1) | PE123299A1 (hu) |
PL (2) | PL191927B1 (hu) |
PT (2) | PT1930330E (hu) |
SI (2) | SI1028961T1 (hu) |
TR (1) | TR200001203T2 (hu) |
TW (1) | TWI232861B (hu) |
UY (1) | UY25225A1 (hu) |
WO (1) | WO1999021855A1 (hu) |
ZA (1) | ZA989767B (hu) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY25225A1 (es) * | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
WO2000027790A1 (en) * | 1998-11-11 | 2000-05-18 | Smithkline Beecham P.L.C. | Mutilin compounds |
GB9912657D0 (en) * | 1999-06-01 | 1999-07-28 | Smithkline Beecham Plc | Novel compounds |
GB9918037D0 (en) * | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
GB9919839D0 (en) * | 1999-08-20 | 1999-10-27 | Smithkline Beecham Plc | Novel compounds |
PL358666A1 (en) | 2000-04-04 | 2004-08-09 | Smithkline Beecham Plc | 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
GB0017031D0 (en) | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
GB0017073D0 (en) * | 2000-07-11 | 2000-08-30 | Univ London | Microorganism |
PE20020676A1 (es) | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
GB0024811D0 (en) * | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
GB0027705D0 (en) * | 2000-11-11 | 2000-12-27 | S P A | Novel compounds |
FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
GB0207495D0 (en) * | 2002-03-28 | 2002-05-08 | Biochemie Gmbh | Organic compounds |
MXPA05000984A (es) * | 2002-07-24 | 2005-09-12 | Sandoz Ag | Derivados de pleuromutilina como antimicrobianos. |
GB0218578D0 (en) * | 2002-08-09 | 2002-09-18 | Glaxo Group Ltd | Novel method |
GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
US7875630B2 (en) * | 2003-09-03 | 2011-01-25 | Glaxo Group Limited | Process salts compositions and use |
WO2005112644A2 (en) * | 2004-05-13 | 2005-12-01 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
US20080171766A1 (en) * | 2005-03-10 | 2008-07-17 | Smithkline Beecham Corporation | Novel Method |
GB0513058D0 (en) * | 2005-06-27 | 2005-08-03 | Sandoz Ag | Organic compounds |
EP2298733B1 (en) * | 2005-06-27 | 2016-05-25 | Nabriva Therapeutics AG | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
WO2007037518A1 (ja) * | 2005-09-29 | 2007-04-05 | Dainippon Sumitomo Pharma Co., Ltd. | ムチリン誘導体及びそれを含有する医薬組成物 |
WO2007079173A2 (en) * | 2005-12-30 | 2007-07-12 | Emergent Biosolutions Inc. | Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents |
CN101605784B (zh) | 2007-02-09 | 2013-04-10 | 安斯泰来制药株式会社 | 氮杂桥环化合物 |
WO2008117796A1 (ja) * | 2007-03-28 | 2008-10-02 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ムチリン誘導体 |
CA2688008A1 (en) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
US20090076071A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched retapamulin |
WO2009070307A1 (en) * | 2007-11-26 | 2009-06-04 | Teva Pharmaceutical Industries Ltd. | Amorphous retapamulin and processes for preparation thereof |
US20090149655A1 (en) * | 2007-12-05 | 2009-06-11 | Lilach Hedvati | Process for the preparation of Retapamulin and its intermediates |
US8278313B2 (en) | 2008-03-11 | 2012-10-02 | Abbott Laboratories | Macrocyclic spiro pyrimidine derivatives |
US8436005B2 (en) | 2008-04-03 | 2013-05-07 | Abbott Laboratories | Macrocyclic pyrimidine derivatives |
US20100184987A1 (en) * | 2008-11-13 | 2010-07-22 | Teva Pharmaceutical Industries Ltd. | Preparation of Retapamulin via its Pleuromutilin-thiol precursor |
US20120107854A1 (en) * | 2009-03-03 | 2012-05-03 | National Institute Of Radiological Sciences | Reagent for measurement of cholinesterase activity |
EP2459563A4 (en) | 2009-07-14 | 2013-01-16 | Albany Molecular Res Inc | 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING AND USING THE SAME |
CN102344397B (zh) * | 2011-08-23 | 2013-09-04 | 浙江升华拜克生物股份有限公司 | 一种伐奈莫林盐酸盐的提纯方法 |
CN103626693B (zh) * | 2012-08-28 | 2016-09-14 | 中国科学院上海药物研究所 | 一类截短侧耳素衍生物、其药物组合物及其合成方法与用途 |
CN103709093B (zh) * | 2012-09-28 | 2016-06-08 | 山东亨利医药科技有限责任公司 | 含有并环的截短侧耳素类抗生素 |
CN111436896A (zh) | 2014-07-21 | 2020-07-24 | 恩多巧爱思股份有限公司 | 多焦、多相机内窥镜系统 |
CN109195608B (zh) * | 2016-03-02 | 2021-05-11 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
CN113845536A (zh) * | 2016-03-02 | 2021-12-28 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
CN106496085B (zh) * | 2016-09-21 | 2018-01-26 | 盐城市舜宝化工有限公司 | 合成盐酸沃尼妙林的中间体化合物以及盐酸沃尼妙林的制备方法 |
TWI762573B (zh) | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
CN111574395B (zh) * | 2020-06-18 | 2021-07-02 | 华南农业大学 | 一种具有酰胺侧链的截短侧耳素衍生物及制备与应用 |
AT523646B1 (de) | 2020-07-21 | 2021-10-15 | Gerd Dr Ascher | Pharmazeutische Verbindungen, ihre Anwendung alleine oder in Kombination, zur Prophylaxe und lokalen Initial-Therapie bei bakteriellen und viralen Infektionen, insbesondere Coronaviren |
US11155514B1 (en) * | 2020-12-19 | 2021-10-26 | Shaanxi University Of Science And Technology | Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same |
US11332430B1 (en) * | 2021-01-25 | 2022-05-17 | Xi'an Taikomed Pharmaceutical Technology Co., Ltd. | Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same |
CN112919463B (zh) * | 2021-04-09 | 2021-10-26 | 南京理工大学 | 一种利用泰妙菌素废盐制备的活性炭及其制备方法 |
CN113121355B (zh) * | 2021-04-13 | 2023-05-09 | 西安康诺化工有限公司 | 一种截短侧耳素大黄酸酯及其制备方法和应用 |
CN114736194A (zh) * | 2022-03-29 | 2022-07-12 | 中牧实业股份有限公司 | 一种具有抗病原微生物活性的含吡啶季铵盐侧链的截短侧耳素衍生物及其制备方法与应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4060542A (en) * | 1969-07-25 | 1977-11-29 | Biochemie Gesellschaft M.B.H. | 14-Desoxy-14 thiocyanato-acetoxy-mutilin |
US4032530A (en) | 1971-10-05 | 1977-06-28 | Sandoz Ltd. | Certain pleuromutilins |
US4208326A (en) | 1971-10-05 | 1980-06-17 | Sandoz Ltd. | Pleuromutilin esters |
US3919290A (en) | 1972-10-03 | 1975-11-11 | Sandoz Ltd | Substituted 14-desoxy-mutilins |
CH575375A5 (hu) | 1972-05-25 | 1976-05-14 | Sandoz Ag | |
BE789629A (fr) * | 1971-10-05 | 1973-04-03 | Sandoz Sa | Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique |
CH593912A5 (en) | 1972-07-07 | 1977-12-30 | Sandoz Ag | Pleuromutilin derivs. - prepd. by acylating derivs. contg. a (4)-hydroxyalkyl-(1)-piperazinyl gp. |
DE2404046C3 (de) | 1974-01-29 | 1984-07-26 | Henkel KGaA, 4000 Düsseldorf | Verwendung von Carboxyl- bzw. Carboxylat- und Hydroxylgruppen aufweisenden Polymeren als Hautfeuchthaltemittel |
US3987194A (en) | 1975-05-12 | 1976-10-19 | E. R. Squibb & Sons, Inc. | Use of pleuromutilin derivatives for the treatment of swine dysentery |
CH619450A5 (hu) | 1976-01-15 | 1980-09-30 | Sandoz Ag | |
US4130709A (en) | 1977-12-08 | 1978-12-19 | Eli Lilly And Company | Pleuromutilin glycoside derivatives |
GB2025930B (en) * | 1978-06-01 | 1983-02-09 | Sandoz Ltd | Process for the production of pleuromutilin derivatives |
JPS5594359A (en) * | 1979-01-12 | 1980-07-17 | Sandoz Ag | Novel pleuromutilin derivatives*their manufacture and use |
EP0013768B1 (en) * | 1979-01-12 | 1984-02-01 | Sandoz Ag | New pleuromutilin derivatives, their production and pharmaceutical compositions containing them |
FR2502951B1 (fr) | 1981-04-06 | 1985-12-06 | Sandoz Sa | Compositions pharmaceutiques topiques sous forme d'une micro-emulsion |
DE3405632A1 (de) * | 1984-02-17 | 1985-08-22 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung |
DE3560511D1 (en) * | 1984-02-17 | 1987-10-01 | Sandoz Ag | Pleuromutilin derivatives, process for their preparation and their use |
AT400674B (de) | 1991-07-24 | 1996-02-26 | Biochemie Gmbh | Pharmazeutische pleuromutilin-zubereitung |
GB9201751D0 (en) | 1992-01-28 | 1992-03-11 | Smithkline Beecham Plc | Compounds |
AT397654B (de) | 1992-05-04 | 1994-06-27 | Biochemie Gmbh | Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung |
CZ189197A3 (cs) | 1994-12-23 | 1998-01-14 | Dr. Karl Thomae Gmbh | Piperazinové deriváty, způsob výroby a farmaceutický prostředek s jejich obsahem |
CN1214039A (zh) | 1996-01-03 | 1999-04-14 | 史密斯克莱·比奇曼公司 | 姆替林的氨基甲酰氧基衍生物及其抗菌素用途 |
HUP0001741A3 (en) | 1996-08-02 | 2000-11-28 | Smithkline Beecham Plc | Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use |
BR9711843A (pt) | 1996-10-01 | 2001-07-31 | Smithkline Beecham Corp | Uso de mupirocina para a fabricação de um medicamento para o tratamento de infecções bacterianas associadas com colonização da nasofaringe por organimos patogênicos |
UY25225A1 (es) * | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
US7875630B2 (en) | 2003-09-03 | 2011-01-25 | Glaxo Group Limited | Process salts compositions and use |
GB0504314D0 (en) | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
-
1996
- 1996-05-07 UY UY25225A patent/UY25225A1/es not_active IP Right Cessation
-
1998
- 1998-10-27 CA CA002307551A patent/CA2307551C/en not_active Expired - Lifetime
- 1998-10-27 KR KR10-2000-7004707A patent/KR100538721B1/ko not_active IP Right Cessation
- 1998-10-27 ES ES08152170T patent/ES2371205T3/es not_active Expired - Lifetime
- 1998-10-27 DE DE69826704T patent/DE69826704T3/de not_active Expired - Lifetime
- 1998-10-27 ZA ZA9809767A patent/ZA989767B/xx unknown
- 1998-10-27 EP EP04076485A patent/EP1452534A1/en not_active Withdrawn
- 1998-10-27 DK DK08152170.0T patent/DK1930330T3/da active
- 1998-10-27 PL PL340254A patent/PL191927B1/pl unknown
- 1998-10-27 IL IL13581198A patent/IL135811A0/xx active IP Right Grant
- 1998-10-27 CZ CZ20001551A patent/CZ298543B6/cs not_active IP Right Cessation
- 1998-10-27 DK DK98950202T patent/DK1028961T5/da active
- 1998-10-27 HU HU0004040A patent/HU229792B1/hu active Protection Beyond IP Right Term
- 1998-10-27 JP JP2000517965A patent/JP4227729B2/ja not_active Expired - Lifetime
- 1998-10-27 WO PCT/GB1998/003211 patent/WO1999021855A1/en active IP Right Grant
- 1998-10-27 US US09/530,446 patent/US6281226B1/en not_active Ceased
- 1998-10-27 CN CNB988127318A patent/CN1205211C/zh not_active Expired - Lifetime
- 1998-10-27 US US13/102,156 patent/USRE43390E1/en not_active Expired - Lifetime
- 1998-10-27 EP EP08152170A patent/EP1930330B1/en not_active Expired - Lifetime
- 1998-10-27 SI SI9830709T patent/SI1028961T1/xx unknown
- 1998-10-27 PT PT08152170T patent/PT1930330E/pt unknown
- 1998-10-27 AU AU96361/98A patent/AU742167C/en not_active Expired
- 1998-10-27 BR BRPI9814747-1A patent/BR9814747B1/pt not_active IP Right Cessation
- 1998-10-27 AT AT98950202T patent/ATE277925T1/de active
- 1998-10-27 SI SI9830932T patent/SI1930330T1/sl unknown
- 1998-10-27 AT AT08152170T patent/ATE525373T1/de active
- 1998-10-27 MY MYPI98004896A patent/MY130665A/en unknown
- 1998-10-27 PL PL375435A patent/PL197672B1/pl unknown
- 1998-10-27 PT PT98950202T patent/PT1028961E/pt unknown
- 1998-10-27 US US10/631,707 patent/USRE39128E1/en not_active Ceased
- 1998-10-27 TR TR2000/01203T patent/TR200001203T2/xx unknown
- 1998-10-27 EP EP98950202A patent/EP1028961B3/en not_active Expired - Lifetime
- 1998-10-27 NZ NZ504203A patent/NZ504203A/xx not_active IP Right Cessation
- 1998-10-27 DE DE122007000076C patent/DE122007000076I2/de active Active
- 1998-10-27 ES ES98950202T patent/ES2229538T7/es active Active
- 1998-10-27 AR ARP980105377A patent/AR015987A1/es active IP Right Grant
- 1998-10-28 DZ DZ980244A patent/DZ2634A1/xx active
- 1998-10-29 PE PE1998001018A patent/PE123299A1/es not_active Application Discontinuation
- 1998-10-29 CO CO98063556A patent/CO5021129A1/es unknown
- 1998-10-29 EG EG132598A patent/EG24177A/xx active
- 1998-11-24 TW TW087119420A patent/TWI232861B/zh not_active IP Right Cessation
-
2000
- 2000-04-24 IL IL135811A patent/IL135811A/en not_active IP Right Cessation
- 2000-04-27 NO NO20002173A patent/NO327392B1/no not_active IP Right Cessation
-
2001
- 2001-02-05 HK HK01100820A patent/HK1031376A1/xx not_active IP Right Cessation
-
2007
- 2007-10-24 LU LU91372C patent/LU91372I2/fr unknown
- 2007-11-06 NL NL300304C patent/NL300304I2/nl unknown
- 2007-11-09 FR FR07C0057C patent/FR07C0057I2/fr active Active
- 2007-11-12 CY CY200700028C patent/CY2007028I1/el unknown
-
2008
- 2008-08-25 JP JP2008215667A patent/JP2009040789A/ja active Pending
-
2009
- 2009-04-01 NO NO20091344A patent/NO20091344L/no not_active Application Discontinuation
- 2009-09-25 NO NO2009023C patent/NO2009023I2/no unknown
-
2011
- 2011-10-31 CY CY20111101037T patent/CY1112062T1/el unknown
-
2014
- 2014-12-18 HU HUS1400060C patent/HUS1400060I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1400060I1 (hu) | Antimikrobiális hatású pleuromutilin-származékok | |
EG24081A (en) | 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives | |
PL334847A1 (en) | Substituted 3-heterocyclyl-benzoyl derivatives | |
HUP0003642A3 (en) | N-alkanoylphenylalanine derivatives | |
GB9702194D0 (en) | Sulphonide derivatives | |
ZA987602B (en) | N-alkanoylphenylalanine derivatives | |
PL335999A1 (en) | Substituted 3-cyanoquinolines | |
AP2000001795A0 (en) | Substituted 4-aminothiazol-2-yol | |
HUP9801168A3 (en) | Triazinylaminostilbene derivatives | |
HK1030371A1 (en) | Antimicrobials | |
IL132982A0 (en) | Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives | |
IL136199A0 (en) | Retraction means | |
GB9715821D0 (en) | Amidino-camptothecin derivatives | |
GB2321457B (en) | 5-Aroylnaphthalene derivatives | |
GB9701628D0 (en) | Imino-aza-anthracyclinone derivatives | |
GB9725541D0 (en) | Amino-benzothiazole derivatives | |
IL130600A0 (en) | Substituted 4-benzoyl-pyrazole | |
ZA983116B (en) | Arylsecocholadiene derivatives | |
HU9800889D0 (en) | New naphtylpiperazine derivatives | |
IL131159A0 (en) | 4-Aminoethoxyindazole derivatives | |
ZA985761B (en) | Substituted aryluracils | |
IL133261A0 (en) | Substituted naphthropyrans | |
GB9706753D0 (en) | Aralkoxy-morphinan derivatives | |
SI1005445T1 (en) | N-alkanoylphenylalanine derivatives | |
PL322697A1 (en) | Novel compound - furane derivatives |